Organon & Co

Recent news

• Rating change
  Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $10
  Market Newswire · 2025/10/28
• Rating change
  Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Cuts Target Price to $9
  Market Newswire · 2025/11/11
• Earnings Flash (OGN) Organon & Co. Posts Q1 Adjusted EPS $0.71 per Share, Vs. FactSet Est of $0.83
  MT Newswires · 2026/4/30
• Earnings Flash (OGN.V) Orogen Royalties Reports Q1 Royalty Revenue C$3.4M; Net Income $4.4M
  MT Newswires · 2026/5/26
• Rating change
  Piper Sandler Downgrades Organon & Co(OGN.US) to Sell Rating, Cuts Target Price to $5
  Market Newswire · 2025/10/27
• Rating change
  Piper Sandler Maintains Organon & Co(OGN.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2025/8/29
• Rating change
  Piper Sandler Upgrades Organon & Co(OGN.US) to Hold Rating, Raises Target Price to $14
  Market Newswire · 2026/4/28
• Earnings Flash (OGN) Organon & Co. Reports Q1 Revenue $1.46B, Vs. FactSet Est of $1.49B
  MT Newswires · 2026/4/30
• Earnings Flash (OGN.V) Orogen Royalties Inc. Reports Q2 Royalty Revenue C$3.2M
  MT Newswires · 2026/8/25
• Company notice
  Organon & Co: Organon & Co. - Anticipated Cash Settlement Option Symbol: OGN
  OCC · 2026/7/8
• Rating change
  Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $9
  Market Newswire · 2026/4/10
• BNP Paribas Maintains Organon & Co(OGN.US) With Buy Rating, Cuts Target Price to $15
  Market Newswire · 2026/4/10
• Rating change
  Organon (OGN.US) plunged due to internal control issues and faced another significant downgrade in its target price by Piper Sandler to $5.
  Zhitong Finance · 2025/10/28
• Rating change
  Barclays Initiates Organon & Co(OGN.US) With Sell Rating, Announces Target Price $7.5
  Market Newswire · 2026/1/21
• Rating change
  J.P. Morgan Keeps Their Sell Rating on Organon (OGN)
  TipRanks · 2025/10/17
• Rating change
  Evercore Maintains Organon & Co(OGN.US) With Hold Rating
  Market Newswire · 2026/4/10
• Rating change
  BofA Securities Maintains Organon & Co(OGN.US) With Sell Rating
  Market Newswire · 2026/2/14
• Rating change
  Piper Sandler Maintains Organon & Co(OGN.US) With Sell Rating, Maintains Target Price $5
  Market Newswire · 2026/4/23
• Rating change
  BNP Paribas Maintains Organon & Co(OGN.US) With Buy Rating, Cuts Target Price to $16
  Market Newswire · 2025/5/23
• Rating change
  Piper Sandler Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $14
  Market Newswire · 2026/4/28

Headlines are aggregated automatically and are not independently verified or edited by our team.